Import Antisera and Other Blood Fractions and Modified Immunological Products, Whether or not Obtained by M from United States
Import trade data for Indian businesses
🇺🇸 United States — Country Profile
Capital
Washington D.C.
GDP (USD)
$25K
Population
331.0M
Currency
US Dollar
Trade Agreement
No preferential agreement
Import Snapshot
India imported $328.0M of antisera and other blood fractions and modified immunological products, whether or not obtained by m from United States in 2024 — -33.4% YoY.
Based on HS Code 3002 import data (UN Comtrade)
Import History — United States to India
2024
$328.0M
HS 3002 imports
2023
$492.6M
HS 3002 imports
2022
$212.4M
HS 3002 imports
About Antisera and Other Blood Fractions and Modified Immunological Products, Whether or not Obtained by M Imports from United States
United States is one of the supplying countries for antisera and other blood fractions and modified immunological products, whether or not obtained by m to the Indian market, classified under HS heading 3002. Indian importers source this product for domestic consumption, manufacturing inputs, or re-export.
Other Countries Supplying Antisera and Other Blood Fractions and Modified Immunological Products, Whether or not Obtained by M to India
Import Antisera and Other Blood Fractions and Modified Immunological Products, Whether or not Obtained by M from United States
Get expert guidance on sourcing, customs procedures, and compliance.
Contact XIMPEX